Latest debt-to-equity ratio
ARS Pharmaceuticals Debt-to-equity ratio
Direct answer
ARS Pharmaceuticals's debt-to-equity ratio is 1,371.51%.
The verified market snapshot reports 1,371.51%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 5, 2026.
Get free ARS Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 1,371.51%
Explore related company data
View ARS Pharmaceuticals's market capitalizationView ARS Pharmaceuticals's price-to-book ratioView ARS Pharmaceuticals's return on equityView ARS Pharmaceuticals's dividend yieldView ARS Pharmaceuticals's 52-week price rangeView ARS Pharmaceuticals's revenue growthView ARS Pharmaceuticals's profit marginView all ARS Pharmaceuticals key metricsReturn to ARS Pharmaceuticals profile